Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02648087

Acronym

NEOSAS

Enrollment

1200

Registered

2016-01-06

Start date

2016-01-31

Completion date

2018-11-30

Last updated

2016-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Cancer

Brief summary

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer. The aim of the study is to evaluate this possibility with the help of a night record of sleep and quality of life questionnaires.

Detailed description

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer. Enrollment 1200 patients This wide sample is expected to respond to the main and secondary objectives of the study

Interventions

DEVICEWith and without SDB

Screening of sleep-disordered breathing (SDB)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* patients with NSCLC undergoing diagnostic * Performance status 0,1,2

Exclusion criteria

* \>75 years * OSA known and in the last 12 months treated PS \>2 * Patients under a long-term oxygen therapy * persons deprived of liberty by judicial decision. * \<18 years

Design outcomes

Primary

Measure	Time frame	Description
Oxygen desaturation index	Between day 1 and day 15	RECORDING BY POLYGRAPHY DEVICE between day 1 and day 15 after enrollment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026